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ABSTRACT
Objective: To determine 7-9 am serum cortisol less than 5mcg/dl is an independent reliable confirmatory
test for the diagnosis of primary adrenal insufficiency (PAI).
Methods: A total of 164 patients who visited the outpatient or inpatient department of Aga Khan University
Hospital from June 2011 to June 2017 were included for the study. All those patients whose levels came
out less than 5mcg/dl were recruited for the study and they all underwent SST. Other demographic and
laboratory data were also recorded.
Results: The sensitivity of morning cortisol for diagnosis of PAI is 100% if levels are <1mcg/dl and decreases
to 71.88% if levels are up to 5mcg/dl.
Conclusion: Morning cortisol is sensitive enough as an alternative to SST if levels are <1mcg/dl (100%).
However, if the levels are increased from >1mcg/dl to <5 mcg/dl, the sensitivity decreases gradually from
98% to 71%.
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INTRODUCTION
Cortisol hormone contribute significantly to
maintaining homeostasis particularly through
their role in the regulation of the body’s adaptive
response to stress, in the maintenance of body
water, electrolyte balance, and in the control of
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blood pressure; The Adrenal cortex synthesizes the
steroid hormones called glucocorticoids (cortisol),
mineralocorticoids (aldosterone) and androgens
in response to hypothalamic-pituitary-adrenal
hormone stimulation via adrenocorticotrophin
hormone (ACTH). The ACTH release cortisol in a
pulsatile manner with approximately 7–15 episodes
daily. The stimulation of cortisol release occurs
within 15 minutes of the surge in ACTH.1
In addition to being pulsatile, the release of
cortisol also follows a circadian rhythm. Release of
cortisol is greatest during early morning waking
hours, with levels declining as the afternoon
progresses. This has a direct impact on how cortisol
values are interpreted according to the timing
of blood sample collection. The release of ACTH
from the anterior pituitary is regulated by the
hypothalamus via corticotropin-releasing hormone
(CRH). Cortisol inhibits the secretion of ACTH
in a negative feedback regulation mechanism.
This closely regulated circuit is referred to as the
hypothalamic-pituitary-adrenal (HPA) axis.
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Primary adrenal insufficiency (PAI) or
Addison’s disease is defined by the inability of
the adrenal cortex to produce sufficient amount
of glucocorticoids and/or mineralocorticoids2 is
a potentially life-threatening condition due to the
central role of these hormones in energy, salt, and
fluid homeostasis.
The symptoms of PAI are quite nonspecific
and include generalized body weakness, fatigue,
body aches, nausea, vomiting, abdominal pain,
depression, and anxiety. As a result, the diagnosis
is frequently delayed, resulting in a clinical
presentation of acute life-threatening adrenal crisis.3
PAI is a rare disease with a reported prevalence of
about 100 to 140 cases per million and an incidence
of 4:1,000,000 per year in Western societies;
autoimmunity is the most common cause of PAI4-7,
followed by infectious diseases such as tuberculosis,
adrenalectomy, neoplasia, and various genetic
causes.
According to guidelines, primary adrenal
insufficiency (PAI) is screened by 8am serum
cortisol level and confirmed by ACTH stimulation
test2, the sensitivity of this test for the diagnosis of
PAI is 92%. As there is a lot of financial constraints
in our country and there is often non-availability of
cosyntropin. Our study aim is to establish whether
7-9am cortisol less than five is an independent
reliable confirmatory test for the diagnosis of
primary adrenal insufficiency.
METHODS
This retrospective study was conducted at
Department of Medicine in collaboration with
section of Chemical Pathology, Department of
Pathology & Laboratory Medicine, Aga Khan
University Hospital (AKUH), and Karachi, Pakistan
from June 2011 to June 2017. Study was commenced
after taking approval from institution’s ethical
review committee (ERC). All patients with cortisol
level of less than 5mcg/dl that underwent ACTH
stimulation test at AKUH laboratory were included.
Patient admitted in intensive care unit (ICU)
were excluded. Cut off used was post synacthen
stimulation was more than 20mcg/dl.
Data analysis: Descriptive analysis consisted
of reporting mean with standard deviation
(for symmetrically distributed variables) or median
with interquartile range (for asymmetrically
distributed variables) for quantitative (continuous)
variables such as age, cortisol levels at baseline, 0
minutes and 60 minutes post synacthen injections.
Frequency with percentages was reported for all
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categorical variable such as gender. Chi-square test
was used to compare proportions across categories
(0 mcg/dl to 5 mcg/dl) for adrenal insufficiency.
Two sample paired t-test was used to compare
pre and post short synacthen tests. The variable of
baseline cortisol level was divided into six categories
(0 to <1 mcg/dl, l to <2 mcg/dl, 2 to <3 mcg/dl, 3
to <4 mcg/dl, 4 to <5 mcg/dl, 5 mcg/dl) while the
variable of post short synacthen test was categorized
into <20 mcg/dl and > 20 mcg/dl. Chi-square test
was used to compare these two above mentioned
variables. Moreover, proportions and percentages
were also reported for each respective category.
A p-value <0.05 was considered as statistically
significant. All analyses were conducted using the
Statistical package for Social Sciences SPSS (version
19.0, copyright © SPSS; 1989-02).
RESULTS
A total of 164 subjects were included in the study.
The mean age of the subjects was 48±15.24 years.
61% (n=100) of the subjects were female while 39%
(n=64) being male.
Mean baseline cortisol level before the synacthen
test was 2.77±0.12mcg/dl. Mean cortisol level
60 minutes after post-synacthen test was
12.85±0.58mcg/dl. Mean difference between
baseline cortisol and 60 minutes post-synacthen
test was 10.075mcg/dl which was highly significant
(p-value <0.001) (Table-I). 140 (85%) study
participants had post-short synacthen cortisol
level < 20mcg/dl while 24 (15%) of them had postsynacthen cortisol level > 20 mcg/dl (Table–II).
Out of the total study participants (11.5%) having
baseline cortisol levels of 0 mcg/dl to <1mcg/dl
with respect to post-synacthen stimulation test after
sixty minutes were 100% (n=19) which showed
Table-I: Pre & post short synacthen tests
(two sample paired t-test).
S. Variables
Mean±S.D
No.			
1.
2.

Baseline cortisol
level
Post synacthen
cortisol level

Mean
Difference

p-value

10.075

< 0.001

2.77±0.12
12.85±0.58

Table-II: Post-short synacthen cortisol level on
stimulation with Tetracosynacthen (ACTH)
after 60 mins as per standard guidelines2.
S. No.

Post-short synacthen cortisol levels

1.
2.

< 20 mcg/dl
≥20 mcg/dl
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Table-III: Baseline cortisol levels and post-synacthen cortisol levels.
S. No.
1.
2.
3.
4.
5.
6.

Baseline cortisol
level mcg/dl

Post-synacthen cortisol
after 60 min <20 mcg/dl no. (%)

Post-synacthen cortisol after
60 min ≥20 mcg/dl no. (%)

0 to <1
1 to < 2
2 to <3
3 to <4
4 to <5
5

19 (100)
44 (97.78)
20 (83.33)
22 (81.48)
23 (71.88)
12 (70.59)

0 (0.00)
1 (2.22)
4 (16.67)
5 (18.52)
9 (28.13)
5 (29.41)

inadequate response. Moreover, 27.4% (n=45) of
the total study participants had baseline cortisol
level of 1 mcg/dl to < 2mcg/dl, while 97.7% (n=44)
had post-synacthen stimulation test as inadequate
response after sixty minutes and 2.2% (n=1)
showed normal response after sixty minutes of the
same category. Out of the total study participants,
14.6 % (n=24) had baseline cortisol levels of 2 mcg/
dl to < 3mcg/dl, among them 83.3% (n=20) subjects
showed inadequate response while 16.6% (n=4)
showed normal response after sixty minutes. In
the category of baseline cortisol levels of 3 mcg/dl
to < 4mcg/dl, 16.4 % (n=27) of total study subjects
were falling in the same range, among them 81.4%
(n=22) had post-synacthen stimulation test as
inadequate response after sixty minutes while
18.5% (n=5) showed normal response after sixty
minutes. Moreover, 19.5% (n=32) of the total study
subjects had baseline cortisol levels of 4mcg/dl to
< 5mcg/dl, among them, 71.8% (n=23) had postsynacthen stimulation as inadequate response,
while 28% (n=9) showed normal response after
sixty minutes. Lastly, 10.6% (n=17) of the total
study subjects had a baseline cortisol level of 5mcg/
dl, among them 70.5% (n=12) had post-synacthen
stimulation as inadequate response after sixty
minutes while 29% (n=5) showed normal response
after sixty minutes. Overall, chi-square test p-value
is highly significant (p-value <0.001) for this table
(Table-III). In addition to this, cross-tabulation
of gender and post-synacthen cortisol level was
statistically insignificant (p-value = 0.72).
DISCUSSION
In this study we have demonstrated that a
morning cortisol value which can be used reliably
as an alternative to SST for the diagnosis of PAI is
≤1 mcg/dl (100% sensitivity). As morning cortisol
values increases from ≥1mcg/dl to ≤5 mcg/dl it
reduces the sensitivity of basal cortisol compared
to SST from 98% to 71% respectively. Our study
did not show any association of gender with
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post SST tests. Age difference between groups
was also not statistically significant. Our data
slightly differs from Endocrine Society Practice
guidelines for Adrenal Insufficiency where a
morning cortisol value of 3mcg/dl is a reliable
cut off for diagnosing PAI2.
There are studies favoring strong correlation
between morning cortisol and response to
Synacthen administration but there is a lack of local
data which could be applied on our population.8
The SST at a conventional dose of 250 mcg has
been validated against the “gold standard” insulin
tolerance test (ITT) for diagnosing suspected AI but
there are significant challenges to the use of SST in
clinical practice including availability of nursing
staff, time to perform this test, financial constraints
and shortage of synacthen in Pakistan therefore the
utility of an alternative test to this dynamic testing
cannot be denied.9
In western countries where tuberculosis is not
endemic the autoimmune Adrenalitis remains
the leading cause of PAI and therefore requires
a validated assay of auto-antibodies against
21-hydroxylase followed by other tests if the
antibody screening is negative thus excluding other
causes.2 In Pakistan Tuberculosis is still considered
as one of the most common causes of PAI.10
The need for introducing dynamic testing
for diagnosing PAI has been due to the broad
range of morning cortisol value i.e. 5–25ug/dL
(139–695nmol/L) as the serum cortisol can be
affected by stress, exercise and food intake3, thus
with chances of missing the borderline cases of
PAI unless a strong clinical suspicion of adrenal
insufficiency. The lack of uniformity in these cutoff levels could in part be credited to differences
in study populations, variability of dynamic tests,
the use of different serum cortisol assays and
dissimilar cut-off peak serum cortisol response
indicative of a normal axis response and the
difference in the clinical context in which the
studies were done. Therefore, Laboratories have
Vol. 35 No. 5

www.pjms.org.pk

1415

Imran Ulhaq et al.

to enforce the need to establish reference values
for given populations, both for basal or stimulated
hormone levels.11
In a meta-analysis of 12 studies (635 subjects), a
basal cortisol level less than 5 μg/dl (138 nmol/liter)
best predicted PAI, whereas values greater than
13 μg/dl (365 nmol/liter) best predicted normal
Hypothalamic Pituitary Axis testing hypothalamicpituitary adrenal insufficiency.12
Woods et al in a study of patients with adrenal
suppression showed lower cut off values in patients
exposed to steroids. A cortisol value of <1.2mcg/
dL (<34 nmol/l) having 100% sensitivity for failing
an SST and values >12.6 mcg/dL with 100%
specificity for passing SST (HPA axis recovery.)
thus concluding that using these cut offs 50% of
SSTs were performed unnecessarily on patients on
inhaled glucorticoids.13
The utility of SST for diagnosing PAI cannot
be denied although its role in central adrenal
insufficiency is still debatable.14 But an alternative
and simple method of predicting the adrenal
cortisol reserves by a morning cortisol level can
avoid unnecessary SST testing thus avoiding cost
issues and the non-availability of synacthan in
different low socioeconomic countries.
We do understand that this is a small data sample
and will require further validation by carrying
out similar trials in other tertiary care centers in
Pakistan but once a consensus is reached regarding
the morning basal cortisol cut off values at which
PAI can be diagnosed in our population, we can
avoid unnecessary SSTs.
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